You are here

HCC

Harbour reports results from HCC combo therapy trial

Harbour reports results from HCC combo therapy trial

Clinical Trials Arena

hepatocellular carcinoma

clinlcal trials

Flag link:

Almost three years after whiffing in a confirmatory study, Merck touts new data for Keytruda in HCC

Almost three years after whiffing in a confirmatory study, Merck touts new data for Keytruda in HCC

Endpoints

Flag link:

Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma

Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma

CP Wire

Flag link: